结膜「黏液表皮样癌」术语修订:基于14例形态、免疫组化及分子发现与2018 WHO眼肿瘤分类
2018年WHO眼肿瘤分类共识会议决定将结膜黏液表皮样癌重新分类为腺鳞癌,认为其形态更符合。为检验该术语的适用性,本研究分析了14例原诊断为结膜黏液表皮样癌的临床、组织病理、免疫组化和分子病理特征,发现所有病变均非黏液表皮样癌,而主要为伴黏液分化的鳞状细胞癌和腺鳞癌,因此建议未来修订WHO分类,将伴黏液分化的鳞状细胞癌与腺鳞癌并列纳入。
要点
- 原诊为结膜黏液表皮样癌的14例均非真性黏液表皮样癌,无MAML2重排。
- 多数病例为伴黏液分化的鳞状细胞癌(55%)或真性腺鳞癌(27%)。
- 建议WHO分类修订纳入伴黏液分化的鳞状细胞癌。
核心结论
- 所有14例原诊为结膜黏液表皮样癌的病变均非黏液表皮样癌,而主要为伴黏液分化的鳞状细胞癌和腺鳞癌。
- 建议未来修订WHO分类,将伴黏液分化的鳞状细胞癌与腺鳞癌并列纳入。
研究设计与样本
- 回顾性分析14例原诊断为结膜黏液表皮样癌的病例。
- 评估临床、组织病理、免疫组化和分子病理特征。
主要发现
- 女性7例(50%),男性7例(50%),中位年龄64岁。
- 原位癌11/14例(79%),包括原位鳞状细胞癌和伴黏液分化的结膜上皮内瘤变(CIN-Muc)。
- 浸润癌11/14例(79%):1/11例(9%)仅为浸润性鳞状细胞癌;6/11例(55%)为伴黏液分化的鳞状细胞癌;3/11例(27%)为真性腺鳞癌;1/11例(9%)为纯腺癌。
- 2例检出高危HPV(16型和18型)。
关键数值与推荐
- 原位病变包括原位鳞状细胞癌和伴黏液分化的结膜上皮内瘤变(CIN-Muc)。
- 伴黏液分化的鳞状细胞癌表现为散在细胞内黏液,偶见细胞间黏液,无真性腺体分化。
临床怎么用
- 病理诊断结膜黏液表皮样癌时应重新评估,多数病例应归类为伴黏液分化的鳞状细胞癌或腺鳞癌。
- MAML2易位检测有助于排除真性黏液表皮样癌。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In 2018, the consensus meeting for the WHO Classification of Tumours of the Eye decided that conjunctival mucoepidermoid carcinoma should be reclassified as adenosquamous carcinoma, as this represented a better morphological fit. To examine the applicability of this terminology, we studied the clinical, histopathological, immunohistochemical and molecular pathology of 14 cases that were originally diagnosed as conjunctival mucoepidermoid carcinoma. There were 7 (50%) females and 7 (50%) males. The median age was 64 years. The left eye was affected in 8 and the right eye in 6 patients. In-situ carcinoma was present in 11/14 (79%) cases and comprised in-situ squamous cell carcinoma (SCC) and conjunctival intraepithelial neoplasia with mucinous differentiation (CIN-Muc). Invasive carcinoma was present in 11/14 (79%) cases. Group 1 (1/11 cases, 9%) comprised invasive SCC only. Group 2 (6/11 cases, 55%) comprised SCC with mucinous differentiation, manifesting as scattered intracellular mucin, occasionally together with intercellular mucin, with no evidence of true glandular differentiation. Group 3 (3/11 cases. 27%) comprised true adenosquamous carcinoma. Group 4 (1/11 cases, 9%) comprised pure adenocarcinoma. Thirteen of 14 cases (93%) underwent FISH for MAML2 translocation and none were rearranged. Two cases harboured high-risk HPV (type 16 and 18). The combined findings confirm that all lesions in our study were not mucoepidermoid carcinoma, but represented predominantly SCC with mucinous differentiation and adenosquamous carcinoma. We, therefore, recommend future revision of the WHO classification to include SCC with mucinous differentiation alongside adenosquamous carcinoma.
引用
- Mudhar HS, Milman T, Zhang PJL, et al. Conjunctival 'mucoepidermoid carcinoma' revisited: a revision of terminology, based on morphologic, immunohistochemical and molecular findings of 14 cases, and the 2018 WHO Classification of Tumours of the Eye. Mod Pathol. 2020. PMID: 31932683. doi:10.1038/s41379-020-0456-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。